Related Experiment Video
Updated: Dec 7, 2025
05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
5.2K
Factors predicting mortality in idiopathic dilated cardiomyopathy
European Heart Journal
|September 1, 1990
Summary
Predicting mortality in dilated cardiomyopathy is possible using clinical factors. Key predictors include symptoms like pulmonary edema, left ventricular dilation, and pulmonary artery pressure, enabling risk stratification for better patient outcomes.
Area of Science:
- Cardiology
- Clinical Research
Background:
- Dilated cardiomyopathy (DCM) is a significant cause of heart failure.
- Identifying predictors of mortality in DCM is crucial for prognosis and management.
Purpose of the Study:
- To identify independent predictors of mortality in patients with dilated cardiomyopathy.
- To develop a predictive score for stratifying mortality risk in DCM patients.
Main Methods:
- Multivariate analysis (Cox Model) of 51 clinical, electrocardiographic, echocardiographic, and hemodynamic parameters in 201 DCM patients.
- Calculation of a quantitative score based on identified predictors.
- Stratification of patients into three risk subgroups based on the score.
Main Results:
- Pulmonary edema, peripheral edema, syncope, symptom duration, end-systolic left ventricular volume, end-diastolic left ventricular diameter, and pulmonary artery systolic pressure were independent predictors of mortality.
- A quantitative score combining these factors accurately predicted death.
- Five-year survival rates were 90% (Group A), 84% (Group B), and 53% (Group C), demonstrating significant risk stratification.
Conclusions:
- Overall survival in this DCM cohort was favorable.
- Clinical severity, left ventricular dilation, pulmonary artery systolic pressure, and symptom duration are key factors defining prognosis.
- A validated score can identify DCM patients at high risk of mortality, guiding clinical decisions.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
234
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
234
01:29Cardiomyopathy V: Interprofessional Care
176
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
176
01:30Cardiomyopathy II: Dilated Cardiomyopathy
272
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
272
01:25Cardiomyopathy I: Introduction and Classification
347
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
347
01:27Heart Failure I: Introduction
550
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
550
01:26Imbalances in Cardiac Output
2.0K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.0K